Management of odontogenic infections and sepsis: an update.


Journal

British dental journal
ISSN: 1476-5373
Titre abrégé: Br Dent J
Pays: England
ID NLM: 7513219

Informations de publication

Date de publication:
09 2020
Historique:
received: 20 04 2020
accepted: 27 05 2020
entrez: 26 9 2020
pubmed: 27 9 2020
medline: 9 10 2020
Statut: ppublish

Résumé

The management of odontogenic infections has improved over recent decades, but further improvements are still required. The ongoing education of GDPs and their dental teams on this issue continues to be important, especially during the current COVID-19 pandemic, where remote triage poses additional difficulties and challenges.Odontogenic infections can lead to sepsis, a potentially life-threatening condition caused by the body's immune system responding in an abnormal way. This can lead to tissue damage, organ failure and death. A patient with non-odontogenic-related infection could also present with sepsis at a dental practice. Early recognition and prompt management of sepsis improves outcomes. GDPs and their dental teams should be trained in the recognition and management of sepsis. Age-specific sepsis decision support tools have been developed by the UK Sepsis Trust to help dental staff recognise and manage patients with suspected sepsis.The aim of this article is to provide an update on the management of odontogenic infections and sepsis.

Identifiants

pubmed: 32978579
doi: 10.1038/s41415-020-2114-5
pii: 10.1038/s41415-020-2114-5
pmc: PMC7517749
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-370

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Oral Maxillofac Surg Clin North Am. 2008 Aug;20(3):353-65
pubmed: 18603196
BMC Oral Health. 2019 Aug 2;19(1):173
pubmed: 31375095
Oral Surg Oral Med Oral Pathol. 1994 May;77(5):446-50
pubmed: 8028865
Infect Dis Clin North Am. 2017 Dec;31(4):593-608
pubmed: 29079150
J Oral Maxillofac Surg. 2013 Jan;71(1):42-6
pubmed: 22726703
J Laryngol Otol. 1994 Feb;108(2):138-43
pubmed: 8163915
Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Nov;132(5):261-4
pubmed: 26347337
Ann Maxillofac Surg. 2012 Jan;2(1):46-50
pubmed: 23482901
Oral Maxillofac Surg Clin North Am. 2013 Aug;25(3):453-65, vi
pubmed: 23660127
Br Dent J. 2007 Sep 8;203(5):241-2
pubmed: 17828174
Emerg Med J. 2004 Mar;21(2):242-3
pubmed: 14988363
Oral Maxillofac Surg Clin North Am. 2003 Feb;15(1):103-10
pubmed: 18088664
Br J Oral Maxillofac Surg. 2020 May;58(4):409-415
pubmed: 31987682
Biogerontology. 2018 Apr;19(2):171-184
pubmed: 29335816
Head Neck. 2001 Feb;23(2):126-33
pubmed: 11303629
Otolaryngol Clin North Am. 2008 Jun;41(3):459-83, vii
pubmed: 18435993
Ghana Med J. 2007 Mar;41(1):33-6
pubmed: 17622338
Br Dent J. 2016 Mar 25;220(6):278
pubmed: 27012326
Arch Otolaryngol Head Neck Surg. 1999 May;125(5):599
pubmed: 10326824
J Oral Maxillofac Surg. 2006 Jul;64(7):1104-13
pubmed: 16781344
Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72
pubmed: 26414292
Oral Maxillofac Surg Clin North Am. 2003 Feb;15(1):17-38
pubmed: 18088657

Auteurs

Phil Jevon (P)

Academy Tutor, Medical Education, Manor Hospital Walsall, UK. phil.jevon@walsallhealthcare.nhs.uk.

Ahmed Abdelrahman (A)

OMFS Speciality Trainee, Manor Hospital Walsall, UK.

Nick Pigadas (N)

Consultant Maxillofacial/Head and Neck Surgeon, Manor Hospital Walsall, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH